ClassID:

92385

C07C205/57 - CPC Classification

Classification description:

Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton

Sub-classes:
Recent Application in this class:
#1
20250074912
2025-03-06

IMPROVED PROCESS FOR THE PREPARATION OF UPADACITINIB

#2
20250058024
2025-02-20

INJECTABLE TOUGH AND VISCOELASTIC BTA HYDROGEL

#3
20240036466
2024-02-01

Onium Salt, Resist Composition, And Patterning Process

#4
20240014395
2024-01-11

NITRO-SUBSITUTED AROMATIC COMPOUNDS FOR USE IN ELECTRODES

#5
20220350243
2022-11-03

RESIST COMPOSITION AND PATTERN FORMING PROCESS

#6
20210184262
2021-06-17

Electrolyte solution for lithium secondary batteries and lithium secondary battery including the same

#7
20210114982
2021-04-22

Indole derivatives and their use as protein kinase inhibitors

#8
20210002320
2021-01-07

CHEMICALLY CLEAVABLE GROUP

#9
20200299755
2020-09-24

Nitrodiarylethenes as fluorescence quenchers for nucleic acid probes

#10
20200002261
2020-01-02

METHODS OF SYNTHESIZING A PROSTACYCLIN ANALOG

#11
20190315713
2019-10-17

Compounds and uses thereof for detection of target molecules in a sample

#12
20190169130
2019-06-06

MULTIPLE-COMPONENT SOLID PHASES CONTAINING AT LEAST ONE ACTIVE PHARMACEUTICAL INGREDIENT

#13
20190135782
2019-05-09

Compounds, compositions, and methods for modulating ferroptosis and treating excitotoxic disorders

#14
20190071399
2019-03-07

Indole derivatives and their use as protein kinase inhibitors

#15
20180258471
2018-09-13

Nitrodiarylethenes as fluorescence quenchers for nucleic acid probes

#16
20180148424
2018-05-31

Method for producing dicarboxylic acid compound

#17
20180141889
2018-05-24

Methods of synthesizing a prostacyclin analog

#18
20180127417
2018-05-10

Intermediates for preparing CGRP receptor antagonists

#19
20170362182
2017-12-21

MULTIPLE-COMPONENT SOLID PHASES CONTAINING AT LEAST ONE ACTIVE PHARMACEUTICAL INGREDIENT

#20
20170297995
2017-10-19

Methods of synthesizing a prostacyclin analog

#21
20170296681
2017-10-19

Compositions and methods for imaging

#22
20170233370
2017-08-17

Compounds, compositions, and methods for modulating ferroptosis and treating excitotoxic disorders

#23
20170210756
2017-07-27

Synthesis of an antiviral compound

#24
20170152253
2017-06-01

Processes and Intermediates for Preparing a Macrocyclic Protease Inhibitor of HCV

#25
20160185743
2016-06-30

15-oxospiramilactone derivatives, preparation method and uses thereof

#26
20160130273
2016-05-12

Process for making CGRP receptor antagonists

#27
20160115182
2016-04-28

One step process for regioselective synthesis of α-acyloxy carbonyls

#28
20160052879
2016-02-25

Process for production of glycopyrronium tosylate

#29
20150344514
2015-12-03

Chemically cleavable group

#30
20150315114
2015-11-05

Methods of Synthesizing a Prostacyclin Analog

#31
20150148550
2015-05-28

Compounds as chloride channel blocking agent

#32
20150112067
2015-04-23

Process for making CGRP receptor antagonists

#33
20150079035
2015-03-19

Compounds, compositions, and methods for modulating ferroptosis and treating excitotoxic disorders

#34
20150025077
2015-01-22

GGA AND GGA DERIVATIVES COMPOSITIONS THEREOF AND METHODS FOR TREATING NEURODEGENERATIVE DISEASES INCLUDING PARALYSIS INCLUDING THEM

#35
20140162989
2014-06-12

Multiple-component solid phases containing at least one active pharmaceutical ingredient

#36
20130296323
2013-11-07

Geranyl geranyl acetone (GGA) derivatives and compositions thereof

#37
20130085283
2013-04-04

GERANYLGERANYLACETONE DERIVATIVES

#38
20130030210
2013-01-31

Methods for preparing amides and amino acids

#39
20130005976
2013-01-03

Processes and intermediates for preparing a macrocyclic protease inhibitor of HCV

#40
20130004679
2013-01-03

Photocrosslinkable materials

#41
20120323014
2012-12-20

Method for producing alpha-acyloxycarbonyl compound and novel alpha-acyloxycarbonyl compound

#42
20120197037
2012-08-02

HYDROLYSABLE LINKERS AND CROSS-LINKERS FOR ABSORBABLE POLYMERS

#43
20120190035
2012-07-26

Detection of disease related genes

#44
20120088920
2012-04-12

Clathrate compound, curing catalyst, composition for forming cured resin, and cured resin

#45
20120088241
2012-04-12

Bioreactive agents

#46
20120076952
2012-03-29

Photocrosslinkable materials

#47
20120029211
2012-02-02

Catalytic Wittig and Mitsunobu reactions

#48
20110280860
2011-11-17

Pharmaceutical compositions comprising monoterpenes

#49
20110129878
2011-06-02

BIOREACTIVE AGENTS

#50
20110021730
2011-01-27

Light sensitive initiator integrated polydimethylsiloxane

#51
20110014567
2011-01-20

Salt and photoresist composition containing the same

#52
20100331566
2010-12-30

SYNTHETIC METHODS AND COMPOSITIONS

#53
20100312003
2010-12-09

METHOD FOR THE PREPARATION OF ORGANIC NITRATES

#54
20100196988
2010-08-05

Bioreactive Agents

#55
20100022744
2010-01-28

CLATHRATE COMPOUND, CURING CATALYST, COMPOSITION FOR FORMING CURED RESIN, AND CURED RESIN

#56
20090322212
2009-12-31

Highly photoluminescent organic compounds, synthesis thereof, and use thereof in electroluminescent devices

#57
20090264676
2009-10-22

Amino acids and catalytic preparatory methods

#58
20090251046
2009-10-08

Electrochromic materials and electrochromic devices using the same

#59
20090176279
2009-07-09

Bioreactive agents

#60
20090082540
2009-03-26

Hydrolysable linkers and cross-linkers for absorbable polymers

#61
20090075253
2009-03-19

BIOREACTIVE AGENTS

#62
20080293888
2008-11-27

Photocrosslinkable materials

#63
20080194859
2008-08-14

Polyurea Compositions and Compounds for the Preparation Thereof

#64
20080188680
2008-08-07

Process Improvement Using Solubility Characteristics

#65
20080177114
2008-07-24

Method for decarboxylating C—C cross-linking of carboxylic acids with carbon electrophiles

#66
20080146742
2008-06-19

Functionalized esters, amides or urethanes of perfluorinated alcohols or amines as surface modifiers

#67
20080139841
2008-06-12

Cobalt-catalyzed oxidations in volumetrically expanded liquids by compressed gases

#68
20070179128
2007-08-02

Substituted spirobenzazepines

#69
20070172849
2007-07-26

Detection of markers in nascent proteins

#70
20070148680
2007-06-28

Detection of disease related genes

#71
20070128680
2007-06-07

Hydrazines and derivatives production process from hydrazines and dicarboxylic acid

#72
20070054958
2007-03-08

Compounds for treatment of lipase-mediated diseases

#73
20070020643
2007-01-25

Photocleavable bioreactive agents

#74
20060275750
2006-12-07

Bioreactive agents

#75
20060247264
2006-11-02

Modulators of the glucocorticoid receptor

#76
20060178356
2006-08-10

Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods

#77
20060063820
2006-03-23

2,6-dihalo-4-(3,3-dichloro-allyloxy)-benzylalcohole derivatives having insecticidal and acaricidal properties

#78
20060030716
2006-02-09

Catalyst comprising cyclic acylurea compound and process for producing organic compounds using the catalyst

#79
20060024704
2006-02-02

Detection of markers in nascent proteins

#80
20050171215
2005-08-04

Germicidal compositions containing halogenated phthalaldehyes, and methods of using such compositions for disinfection or sterilization

#81
20050165247
2005-07-28

Method for producing substituted nitro benzoic acids by oxidation of corresponding nitro toluenes, nitro benzyl alcohols, esters and/or ethers

#82
20050142155
2005-06-30

Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods

#83
20050113416
2005-05-26

Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods

#84
20050074748
2005-04-07

Bioreactive agents

#85
20050020439
2005-01-27

Catalyst comprising cyclic acylurea compounds and processes for production organic compounds with the same

#86
18353000
2025-01-07

Ferroelectric nematic composition and device thereof